The EU Commission approves, subject to remedies, a merger in the medical devices market giving a practical example of the use of quantitative analyses in merger control (GE Medical Systems / Instrumentarium)

"GE/Instrumentarium: a practical example of the use of quantitative analyses in merger control"* On 2 September 2003, the European Commission approved, subject to conditions, the acquisition by General Electric Medical Systems (‘GE’) of the Finnish firm Instrumentarium. The Commission was concerned that GE and Instrumentarium would hold too high a share of the patient monitoring market, which would have been detrimental to hospitals. The Commission’s concerns were removed following GE’s offer to sell off Spacelabs, a one-year-old acquisition by Instrumentarium, together with a series of supply agreements, as well as the commitment to ensure interoperability of its anaesthesia equipment, patient monitors and clinical information systems with third parties’ devices. This case illustrates

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Benoît Durand, Guillaume Loriot, François-Xavier Rouxel, The EU Commission approves, subject to remedies, a merger in the medical devices market giving a practical example of the use of quantitative analyses in merger control (GE Medical Systems / Instrumentarium), 2 September 2003, e-Competitions September 2003, Art. N° 38385

Visites 342

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues